Ammonium Chloride → 4-(3,4-difluorobenzyl)-3-oxo-N-{(1R)-2-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy]-1-phenylethyl}-3,4-dihydropyrazine-2-carboxamide

HRID 1038979ノート

反応式

HRID 1038979 の反応式
[F:1][C:2]1[CH:3]=[C:4]([CH:16]=[CH:17][C:18]=1[F:19])[CH2:5][N:6]1[CH:11]=[CH:10][N:9]=[C:8]([C:12]([OH:14])=O)[C:7]1=[O:15].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C.[NH2:53][C@H:54]([C:67]1[CH:72]=[CH:71][CH:70]=[CH:69][CH:68]=1)[CH2:55][O:56][C:57]1[CH:66]=[CH:65][C:60]2[NH:61][C:62](=[O:64])[NH:63][C:59]=2[CH:58]=1.[NH4+].[Cl-]>CN1C(=O)CCC1.C(OCC)(=O)C>[F:1][C:2]1[CH:3]=[C:4]([CH:16]=[CH:17][C:18]=1[F:19])[CH2:5][N:6]1[CH:11]=[CH:10][N:9]=[C:8]([C:12]([NH:53][C@H:54]([C:67]2[CH:72]=[CH:71][CH:70]=[CH:69][CH:68]=2)[CH2:55][O:56][C:57]2[CH:66]=[CH:65][C:60]3[NH:61][C:62](=[O:64])[NH:63][C:59]=3[CH:58]=2)=[O:14])[C:7]1=[O:15]

参加物

8

反応物 5

HCID 25517Ammonium ChlorideHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 584430534-(3,4-Difluorobenzyl)-3-oxo-3,4-dihydropyrazine-2-carboxylic acidHCID 67395993(R)-5-(2-Amino-2-phenylethoxy)-1H-benzo[d]imidazol-2(3H)-one

生成物 1

HCID 462348434-(3,4-difluorobenzyl)-3-oxo-N-{(1R)-2-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy]-1-phenylethyl}-3,4-dihydropyrazine-2-carboxamide

試薬・触媒・溶媒 2

HCID 8857Ethyl Acetate溶媒HCID 13387N-methyl-2-pyrrolidone溶媒2 回

実験手順

4-(3,4-Difluorobenzyl)-3-oxo-3,4-dihydropyrazine-2-carboxylic acid (48 mg, 0.18 mmol) was placed in a 25-mL RBF under a nitrogen atmosphere followed by HATU (82 mg, 0.22 mmol), then NMP (1.0 mL) and finally N,N-diisopropylethylamine (0.11 mL, 0.63 mmol). The reaction was stirred for five minutes at room temperature, and was added to a solution of 5-[(2R)-2-amino-2-phenylethoxy]-1,3-dihydro-2H-benzimidazol-2-one (55 mg, 0.18 mmol) in NMP (1.0 mL). The reaction was allowed to stir at room temperature for forty minutes, then was added to a separatory funnel containing ethyl acetate (75 mL) and dilute aqueous NH4Cl (50 mL); the phases were separated and the organic layer was washed with saturated aqueous NaHCO3 (50 mL), followed by brine (50 mL) and dried over anhydrous Na2SO4, then concentrated in vacuo. The crude product was purified by silica gel chromatography (10-gram column) using 0-10% CH3OH in CH2Cl2, with the product eluting at 8% CH3OH in CH2Cl2, to afford 4-(3,4-difluorobenzyl)-3-oxo-N-{(1R)-2-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy]-1-phenylethyl}-3,4-dihydropyrazine-2-carboxamide as a light yellow solid. 1H NMR (500 MHz, C2D6SO) δ 10.51 (s, 1H), 10.38 (s, 1H), 9.82 (d, 1H), 8.05 (d, 1H), 7.57 (d, 1H), 7.50 (m, 1H), 7.43 (m, 3H), 7.35 (t, 2H), 7.27 (t, 1H), 7.24 (m, 1H), 6.75 (d, 1H), 6.51 (d, 2H), 5.34 (m, 1H), 5.16 (s, 2H), 4.09 (m, 2H). LRMS (ESI) calc'd for (C27H23F2N5O4) [M+H]+, 518.2; found 518.2.

後処理

  1. stirringto stir at room temperature for forty minutes
  2. additionwas added to a separatory funnel
  3. customthe phases were separated
  4. washthe organic layer was washed with saturated aqueous NaHCO3 (50 mL)
  5. dry with materialdried over anhydrous Na2SO4
  6. concentrationconcentrated in vacuo
  7. customThe crude product was purified by silica gel chromatography (10-gram column)
  8. washwith the product eluting at 8% CH3OH in CH2Cl2

出典と根拠

ORDレコード
ord-34d0131ebbdf4b6e84b30f491e99bc5b
出典データセット
uspto-grants-2013_10
特許番号
US08552019B2

反応ノート

読み込み中…